Idiopathic Membranous Nephropathy
Conditions
Interventions
Experimental group:Moshen Digui prescription by ultrasound infiltration
control group :placebo by ultrasound infiltration
Sponsors
Beijing Hospital of Traditional Chinese Medicine, Affiliated to the Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Conform to Western medical diagnostic criteria and TCM syndrome differentiation standards; (2) 24-hour urinary protein quantitation <4g/d and normal renal function (continuous monitoring twice or more); (3) No application of ACEI/ARB contraindications: renal artery stenosis, hyperkalemia, solitary kidney, etc.; (4) Aged 18-75 years; (5) Signing informed consent and willingness to complete the treatment.
Exclusion criteria
Exclusion criteria: (1) Hormones, immunosuppressants and/or Tripterygium glycoside tablets have been used in the past six months. (2) Patients with acute renal failure; (3) Infections, hypertension, and other complications have not been effectively controlled; (4) Incorporate severe primary diseases such as heart, brain, liver or hematopoietic system, malignant tumors, and psychotic patients; (5) Allergies or those who are allergic to multiple drugs; (6) Patients with damaged skin at the waist; (7) Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urine protein concentration in 24 hours; | — |
Secondary
| Measure | Time frame |
|---|---|
| serum albumin;plasma total protein;BUN;SCr;eGFR; | — |
Countries
China
Contacts
Public ContactWenjing Zhao
Department of nephrology, Beijing Hospital of Traditional Chinese Medicine, Affiliated to the Capital Medical University
Outcome results
None listed